Delivery Order SPE2DB22D3102-SPE2DB25FL2YB
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Lamotrigine ER 200 mg tablets in 30-count quantities. This contract, valued at $1,133.76, represents a firm fixed-price delivery order with an ultimate completion date of September 5, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,910.41 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ER 250 mg tablets (30-count packages). This contract, awarded on August 5, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Lamotrigine ER 25 mg tablets in quantities of 30, with a ceiling value of $1,517.04. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lamotrigine ER 300 mg tablets (30-count units) with a ceiling value of $1,331.43. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on September 11, 2025, with performance to be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.28 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price, competitively awarded delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lamotrigine ODT 100 mg tablets (30-unit quantity) under a firm fixed-price contract valued at $11,986.07. This non-set-aside competitive award represents a single delivery order for this generic neurological medication, with an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lamotrigine ER 300 mg tablets in a quantity of 30 units, valued at $2,357.64. This delivery order represents a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 250 mg tablets (30-count supply) valued at $3,688.24, with an award date of August 12, 2025, and ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used in...
- The Defense Logistics Agency awarded a delivery order valued at $1,323.38 to AmerisourceBergen Drug Corp for Lamotrigine ER 200 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. Lamotrigine is a generic anticonvulsant and mood-stabilizing medication commonly used in military...
- The Defense Logistics Agency awarded a delivery order valued at $4,824.31 to AmerisourceBergen Drug Corp for Lamotrigine ER 50 mg tablets (30-count) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used for seizure management and bipolar...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2YBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lamotrigine ER 25 mg tablets in 30-count units, with a ceiling value of $1,264.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this contract award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and established federal contractor, serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. The company's role within the Defense Logistics Agency's medical supply chain enables it to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with pharmaceutical commodities and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/10/25 |